Majeed, B.J.M.; Saadallah, M.A.; Al-Ani, I.H.; El-Tanani, M.K.; Al Azzam, K.M.; Abdallah, H.H.; Al-Hajji, F.
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals 2024, 17, 737.
https://doi.org/10.3390/ph17060737
AMA Style
Majeed BJM, Saadallah MA, Al-Ani IH, El-Tanani MK, Al Azzam KM, Abdallah HH, Al-Hajji F.
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals. 2024; 17(6):737.
https://doi.org/10.3390/ph17060737
Chicago/Turabian Style
Majeed, Bashar J. M., Mohammed A. Saadallah, Israa H. Al-Ani, Mohamed K. El-Tanani, Khaldun M. Al Azzam, Hassan H. Abdallah, and Feras Al-Hajji.
2024. "Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib" Pharmaceuticals 17, no. 6: 737.
https://doi.org/10.3390/ph17060737
APA Style
Majeed, B. J. M., Saadallah, M. A., Al-Ani, I. H., El-Tanani, M. K., Al Azzam, K. M., Abdallah, H. H., & Al-Hajji, F.
(2024). Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals, 17(6), 737.
https://doi.org/10.3390/ph17060737
